三博脑科收盘上涨5.12%，滚动市盈率102.32倍，总市值112.45亿元

Group 1 - The core viewpoint of the articles highlights the performance and valuation of Sanbo Brain Science, which closed at 54.59 yuan, up 5.12%, with a rolling PE ratio of 102.32, marking a new low in 96 days, and a total market capitalization of 11.245 billion yuan [1] - The average PE ratio for the medical services industry is 46.96, with a median of 57.43, placing Sanbo Brain Science at the 38th position within the industry [1] - As of the first quarter of 2025, only one institution holds shares in Sanbo Brain Science, with a total of 535,900 shares valued at 2.8 million yuan [1] Group 2 - Sanbo Brain Science's main business is clinical medical services, with primary products including medical services, pharmaceuticals, supply chain, and other businesses [1] - The latest performance report for the first quarter of 2025 shows that the company achieved operating revenue of 393 million yuan, a year-on-year increase of 16.78%, and a net profit of 38.3136 million yuan, a year-on-year increase of 14.56%, with a gross profit margin of 26.44% [1] - The PE ratios for Sanbo Brain Science are 102.32 (TTM) and 107.06 (static), with a price-to-book ratio of 4.81 [2]